REGMF (RemeGen Co) Short Interest


REGMF RemeGen Co Ltd REGMF
41 GF Score
Price $12.05
GF Value $31.89
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is RemeGen Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

REGMF vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, RemeGen Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's Short Interest distribution charts can be found below:

* The bar in red indicates where RemeGen Co's Short Interest falls into.


REGMF
41GF Score
RemeGen Co Ltd REGMF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RemeGen Co (REGMF) Overvalued in 2026?

Based on GuruFocus' analysis, RemeGen Co stock appears to be undervalued. The current stock price of $12.05 is trading 62.2% below its estimated GF Value™ of $31.89. GuruFocus considers RemeGen Co to be Possible Value Trap.

Key valuation signals for REGMF:

  • Short Interest:
  • GF Value™: $31.89 vs. price of $12.05 (62.2% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the REGMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RemeGen Co Business Description

Address 58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN
RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat severe diseases such as autoimmune diseases, oncology, and ophthalmology. It has its operations in China and the USA and derives the majority of its revenue from China.
41GF Score

Get the complete analysis for REGMF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.05
Price
$31.89
GF Value